# Tracy Beth Høeg

Type: Person

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/tracy-beth-heg
Canonical HTML page: https://getbiobrief.com/entity/tracy-beth-heg

## Timeline

- **2026-09-08**: HHS announces permanent FDA center directors — Four senior positions filled, including permanent directors for drugs, vaccines/biologics, and tobacco products.
- **2026-05**: Tracy Beth Høeg departs CDER — Høeg says she was fired as director of the FDA's Center for Drug Evaluation and Research.
- **2026-05**: Michael Davis assumes acting CDER director — Davis steps in as acting director of CDER following Høeg's departure.
- **2025**: Michael Davis returns to FDA as deputy director — Davis rejoins the agency after working at a nonprofit pursuing psychedelic drug development.

## Recent coverage (1 stories)

### FDA Names 4 Center Directors as Psychedelics Reviews Take Shape
2026-09-09 16:42:11 · Sentiment: Neutral · Impact: 6/10 · Sources: 2

The FDA's new permanent CDER director is Michael Davis, whose psychiatric drug and psychedelic nonprofit background aligns with White House calls for faster psilocybin, MDMA, and LSD reviews. Vaccine and tobacco center leadership also stabilized.
Full story: https://getbiobrief.com/story/fda-cder-psychedelics-biotech

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.